Key Points
- CEO Aaron Green sold 61,555 shares on Nov. 18 at an average price of $1.20 for $73,866, reducing his stake to 1,804,103 shares (a 3.3% decrease); he also sold 64,767 shares on Oct. 22 at $2.23.
- OneMedNet (ONMD) has a market cap of $65.8M, a negative P/E of -25.8, a one‑year range of $0.30–$4.22, 50/200‑day moving averages of $1.73/$1.14, and reported quarterly EPS of ($0.01) on $0.18M in revenue.
- Institutional ownership is low (~0.95%) despite recent large hedge fund buys, and analysts' consensus rating on the stock is a "Sell".
OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) CEO Aaron Green sold 61,555 shares of the business's stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $1.20, for a total transaction of $73,866.00. Following the sale, the chief executive officer owned 1,804,103 shares of the company's stock, valued at approximately $2,164,923.60. This represents a 3.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Aaron Green also recently made the following trade(s):
- On Wednesday, October 22nd, Aaron Green sold 64,767 shares of OneMedNet stock. The stock was sold at an average price of $2.23, for a total value of $144,430.41.
OneMedNet Price Performance
Shares of ONMD opened at $1.29 on Wednesday. The firm has a market capitalization of $65.80 million, a P/E ratio of -25.80 and a beta of 1.10. OneMedNet Corporation has a one year low of $0.30 and a one year high of $4.22. The business has a fifty day moving average of $1.73 and a 200 day moving average of $1.14.
OneMedNet (NASDAQ:ONMD - Get Free Report) last announced its earnings results on Friday, November 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.18 million during the quarter.
Hedge Funds Weigh In On OneMedNet
A number of hedge funds have recently modified their holdings of ONMD. Correct Capital Wealth Management purchased a new stake in shares of OneMedNet in the third quarter worth $4,910,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of OneMedNet during the 3rd quarter valued at $25,000. Finally, Exencial Wealth Advisors LLC boosted its holdings in OneMedNet by 141.3% in the 3rd quarter. Exencial Wealth Advisors LLC now owns 3,599,460 shares of the company's stock worth $3,923,000 after buying an additional 2,107,598 shares during the period. 0.95% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
ONMD has been the subject of several recent research reports. Wall Street Zen upgraded shares of OneMedNet to a "hold" rating in a research report on Friday, September 26th. Weiss Ratings reiterated a "sell (d-)" rating on shares of OneMedNet in a research note on Tuesday, October 14th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of "Sell".
Check Out Our Latest Analysis on OneMedNet
About OneMedNet
(
Get Free Report)
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
